Document Detail


Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?
MedLine Citation:
PMID:  10969685     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The large number of experimental studies showing that adenosine "turns on" the protein kinase C (PKC)-mediated pathway that accounts for the cardioprotection conferred by ischemic preconditioning contrasts with the scarcity of clinical data documenting the preconditioning-like protective effect of adenosine during cardiac operations on humans. METHODS: Forty-five patients undergoing coronary artery bypass were randomized to receive, after the onset of cardiopulmonary bypass, a 5-minute infusion of adenosine (140 microg x kg(-1) x min(-1)) followed by 10 minutes of washout before cardioplegic arrest (n = 23) or an equivalent period (15 minutes) of prearrest drug-free bypass (controls, n = 22). Outcome measurements included troponin I release over the first 48 postoperative hours and activity of ecto-5'-nucleotidase, an admitted reporter of PKC activation, as assessed on right atrial biopsies taken before bypass and at the end of the preconditioning protocol (or after 15 minutes of bypass in control patients). RESULTS: Aortic cross-clamping times were not different between the two groups. Likewise, prebypass values of ecto-5'-nucleotidase (nanomoles/mg protein per minute) were similar in control (3.14+/-1.02) and adenosine-treated (2.66+/-1.08) patients. They subsequently remained unchanged in control patients (3.87+/-1.65) whereas they significantly increased after adenosine preconditioning (4.47+/-1.96, p<0.001 versus base line values). However, peak postoperative values of troponin I (microg/L) were not significantly different between control (4.8+/-2.8) and adenosine-preconditioned patients (5.9+/-6.6) nor were the areas under the curve. There were no adverse effects related to adenosine. CONCLUSIONS: Adenosine, given at a clinically safe dose, can turn on the PKC-mediated signaling pathway involved in preconditioning but this biochemical event does not translate into reduced cell necrosis after coronary artery surgery, suggesting that a preconditioning-like protocol may not be the best suited for exploiting the otherwise well-documented cardioprotective effetcs of adenosine.
Authors:
D Belhomme; J Peynet; E Florens; O Tibourtine; M Kitakaze; P Menasché
Related Documents :
10839925 - Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: mec...
16464635 - Percutaneous endocardial injection of erythropoietin: assessment of cardioprotection by...
11123255 - Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on bo...
15492595 - Remifentanil limits infarct size but attenuates preconditioning-induced infarct limitat...
15133355 - Efficacy of a microwave antenna for ablation of the tricuspid valve--inferior vena cava...
17584565 - Diastolic function assessment in clinical practice: the value of 2-dimensional echocard...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  70     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-09-27     Completed Date:  2000-09-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  590-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiovascular Surgery, Hôpital Bichat, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / pharmacology*
Aged
Coronary Artery Bypass*
Female
Heart / drug effects*
Humans
Ischemic Preconditioning, Myocardial*
Male
Middle Aged
Protein Kinase C / physiology
Signal Transduction / drug effects
Vasodilator Agents / pharmacology*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 58-61-7/Adenosine; EC 2.7.11.13/Protein Kinase C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neutrophil degranulation and complement activation during fetal cardiac bypass.
Next Document:  Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener p...